About
Titles
Assistant Professor
Appointments
Hematology
Assistant ProfessorPrimary
Other Departments & Organizations
Education & Training
- PhD
- Yale Graduate School of Arts and Sciences, Investigative Medicine
- Hematology/Oncology Fellow
- Yale University (2019)
- Internal Medicine
- Duke University (2016)
- MD
- The George Washington University School of Medicine, (2013)
- BS
- University of Maryland, Biological Sciences (2003)
Board Certifications
Medical Oncology
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2019
Hematology (Internal Medicine)
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2019
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2016
Research
Publications
2021
There won'T be blood.
Gower M, Foster G, Tikhonova AN. There won'T be blood. Nature Immunology 2021, 22: 396-397. PMID: 33753941, DOI: 10.1038/s41590-021-00893-6.Peer-Reviewed Original Research
2018
Treatment with Foscarnet after Allogeneic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function
Foster Y, Grant M, Thomas S, Cameron B, Raiff D, Corbet K, Ferreri C, Horwitz M. Treatment with Foscarnet after Allogeneic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function. Blood 2018, 132: 4594. DOI: 10.1182/blood-2018-99-113189.Peer-Reviewed Original ResearchConceptsLong-term renal functionAcute kidney failureAcute kidney injuryChronic kidney diseaseRenal functionChronic GVHDNephrotoxic drugsHuman herpes virus-6 (HHV-6) reactivationAllogeneic hematopoietic cell transplantEnd-stage renal diseaseAlternative donor graftsHHV-6 viremiaUnadjusted median survivalRetrospective cohort studyHematopoietic cell transplantTransplant-related factorsGlomerular filtration rateSerum creatinine valuesMultivariate logistic regressionCKD-EPI equationUmbilical cord bloodManual chart reviewAcute GVHDEGFR declineLower eGFRs
2016
An Outbreak of Beta-2 Adrenergic Toxicity from Adulterated Heroin
Ali M, Foster Y, Brooks M, Roomiany P. An Outbreak of Beta-2 Adrenergic Toxicity from Adulterated Heroin. The American Journal Of Medicine 2016, 129: e125-e126. PMID: 27103048, PMCID: PMC6051537, DOI: 10.1016/j.amjmed.2016.03.027.Peer-Reviewed Original ResearchCitationsAltmetricKeratomalacia in a Patient With Psychogenic Vitamin A Deficiency
Gospe SM, Todorich B, Foster YG, Legault G, Woods SK, Proia AD, Daluvoy M. Keratomalacia in a Patient With Psychogenic Vitamin A Deficiency. Cornea 2016, 35: 405-407. PMID: 26785304, DOI: 10.1097/ico.0000000000000732.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCorneal meltRight eyeHigh-dose vitamin ALarge corneal epithelial defectAnterior chamber inflammationPainful vision lossCorneal epithelial defectsVitamin A DeficiencySelf-induced vomitingBilateral keratomalaciaConjunctival xerosisLeft eyeSevere vitaminHistopathological findingsHistological findingsEpithelial defectsSerum vitaminCase reportVision lossGastrointestinal abnormalitiesA DeficiencyPanic disorderVitamin APatientsStrong indexPulse Cyclophosphamide for Steroid-Refractory Chronic Graft-Versus-Host Disease
Chao N, Foster Y, Rowe K, Shah A, Cardones A. Pulse Cyclophosphamide for Steroid-Refractory Chronic Graft-Versus-Host Disease. Transplantation And Cellular Therapy 2016, 22: s393-s395. DOI: 10.1016/j.bbmt.2015.11.918.Peer-Reviewed Original ResearchCitationsAltmetric
Academic Achievements and Community Involvement
honor Women in Cancer Immunotherapy Network Leadership Institute
International AwardSociety for Immunotherapy of CancerDetails08/02/2021United States